TH9507 in Patients With HIV-Associated Lipodystrophy
Registered trial of TH9507/tesamorelin in HIV-associated lipodystrophy; actual enrollment shown.
Phase
Phase 3
Study type
Interventional
Enrollment
412
Population / condition
HIV Infections, Lipodystrophy
Registry last updated
2013-11-27
Interpretation. Registry has no posted results section but links a published trial report; absence of posted registry results does not mean no published results. Last-update date was marked estimated by the registry.
Try a compound name, remove a search word or select a different type. Clear filters to see the complete index.
Follow the source, not just the summary
This index is deliberately selective. It does not include every relevant study, and missing records are not evidence that no research exists. Search ClinicalTrials.gov for the wider literature.